Jonathan Seah

Jonathan has over 25 years of experience in clinical medicine, investment banking, private equity, and general management in the US, China, and Southeast Asia. He holds an MBA from Harvard Business School and a Bachelor’s Degree in Medicine from the Royal College of Surgeons in Ireland. Jonathan was the founding CEO of Parkway Health’s China Division (now part of IHH) where he built the organization through new facilities and acquisitions over a five-year period while under the ownership of TPG. A minority stake in this business was recently sold to Taikang Insurance for an approximate valuation of USD500m. Most recently, Jonathan was CEO and Chairman of China Medical & HealthCare Group (CMHG). CMHG is a publicly-listed healthcare and investment company on the Hong Kong Stock Exchange with a market capitalization of approximately USD 700 million. He was also previously the CEO of First Steamship (a publicly-listed shipping company in Taipei), and the Business Development Director at Biotronik USA in Oregon. Prior to this Dr Seah was a corporate finance investment banker with Merrill Lynch, in Palo Alto, California. Before business school, Dr Seah was a medical doctor in Singapore, at the National University Hospital, Tan Tock Seng Hospital, and at the Raffles Medical Group. He sits or has sat on the boards of several private and public companies, including Zenitas, a publicly-listed allied healthcare company in Australia, Yuneec, a leading drone manufacturer in China, and Grand Ocean, a department store company in China. Jonathan is a member of the YPO and the advisory board of the New York Philharmonic Orchestra